Cargando…
Intrapleural combination therapy with lobaplatin and erythromycin for non‐small cell lung cancer‐mediated malignant pleural effusion
BACKGROUND: Malignant pleural effusion is a common complication of non‐small cell lung cancer (NSCLC); however, treatment options remain limited. This study evaluated the safety and efficacy of sequential intrapleural therapy with lobaplatin and erythromycin for NSCLC‐mediated malignant pleural effu...
Autores principales: | Xu, Lisheng, Wang, Benjie, Gao, Meimei, Zhang, Yan, Qi, Qian, Li, Tao, Li, Caiyu, Wang, Aihua, Li, Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley & Sons Australia, Ltd
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6068459/ https://www.ncbi.nlm.nih.gov/pubmed/29917319 http://dx.doi.org/10.1111/1759-7714.12768 |
Ejemplares similares
-
Intrapleural treatment in patients with non‐small cell lung cancer with malignant pleural effusions in the real world
por: Pan, Pengfei, et al.
Publicado: (2021) -
Thoracic perfusion of lobaplatin combined with endostar for treating malignant pleural effusions: A meta-analysis and systematic review
por: Wang, Cheng-Qian, et al.
Publicado: (2022) -
Simple intrapleural hyperthermia at thoracoscopic exploration to treat malignant pleural effusion
por: Moon, Youngkyu, et al.
Publicado: (2015) -
Intrapleural Tenecteplase for Complicated Parapneumonic Pleural Effusion
por: Kadhem, Husain, et al.
Publicado: (2021) -
Ambulatory Intrapleural Fibrinolytic Therapy in Highly Viscous Recurrent Malignant Pleural Effusion
por: Foo, Chuan Tai, et al.
Publicado: (2021)